MNST:NASDAQMonster Beverage Corporation Analysis
Data as of 2026-05-21 - not real-time
$86.88
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Monster Beverage is trading at $86.88, comfortably above its 20‑day (81.21) and 50‑day (77.29) SMAs, indicating a strong bullish bias. The 14‑day RSI at 67.27 signals momentum but approaches overbought territory. MACD remains bullish with the line (3.03) above the signal (2.35) and a positive histogram. Technicals are supported by a solid price floor around $74.60 and a nearby resistance near $88.77, just shy of the 52‑week high. Volatility is elevated at 42% over the past 30 days, yet beta is low (~0.36), suggesting price swings are more company‑specific than market‑driven. The company posted 26.9% YoY revenue growth to $2.35 B in Q1 2026, with gross margins of 55% and operating margins above 31%, underscoring its profitability engine.
Cash generation is robust, with $2.19 B operating cash flow and $1.68 B free cash flow, while net debt is modest at $94 M. Return on equity stands at 26.7%, reflecting efficient capital use. Despite these strengths, the DCF‑derived fair value of $63.28 implies the stock is priced well above intrinsic estimates, offering only ~2% upside. The forward PE of 33.7 and a trailing PE near 42 place the stock in a premium valuation range. Recent news highlights an earnings beat, a newly authorized share‑repurchase program, and an upgrade from Rothschild & Co to “Buy.” Consequently, the momentum is positive, but limited upside tempers short‑term enthusiasm.
Cash generation is robust, with $2.19 B operating cash flow and $1.68 B free cash flow, while net debt is modest at $94 M. Return on equity stands at 26.7%, reflecting efficient capital use. Despite these strengths, the DCF‑derived fair value of $63.28 implies the stock is priced well above intrinsic estimates, offering only ~2% upside. The forward PE of 33.7 and a trailing PE near 42 place the stock in a premium valuation range. Recent news highlights an earnings beat, a newly authorized share‑repurchase program, and an upgrade from Rothschild & Co to “Buy.” Consequently, the momentum is positive, but limited upside tempers short‑term enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technicals but limited upside near resistance
- Recent earnings beat and share‑repurchase program
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high profitability margins
- Robust cash flow generation and low debt
- Analyst upgrade to Buy and continued brand expansion
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable brand portfolio and diversification into alcohol & hard seltzer
- High ROE and efficient capital deployment
- Defensive consumer positioning with low beta and solid balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth26.90%
Profit Margin23.11%
P/E Ratio42.0
ROE26.65%
ROA17.72%
Debt/Equity1.08
P/B Ratio9.7
Op. Cash Flow$2.2B
Free Cash Flow$1.7B
Technical Analysis
TrendBullish
RSI67.3
Support$74.60
Resistance$88.77
MA 20$81.21
MA 50$77.29
MA 200$73.46
MACDBullish
VolumeIncreasing
Fear & Greed Index89.71
Valuation
Fair Value$63.28
Target Price$88.68
Upside/Downside2.07%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.37
Volatility42.00%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.